Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 145,877 |
|
|||||
| News | - | ||||||
| Day High | 2.56 | Low High |
|||||
| Day Low | 2.47 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Athira Pharma Inc | ATHA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.01 | -0.39% | 2.54 | 00:00:06 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.52 | 2.47 | 2.56 | 2.54 | 2.55 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 747 | 145,877 | $ 2.51 | $ 366,233 | - | 1.33 - 4.2984 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:14:57 | 8 | $ 2.49 | USD |
Athira Pharma Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 98.12M | 38.33M | - | 1.63M | -117.67M | -3.07 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Athira Pharma News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ATHA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.51 | 2.62 | 2.44 | 2.56 | 133,681 | 0.03 | 1.20% |
| 1 Month | 2.70 | 2.72 | 2.44 | 2.55 | 141,901 | -0.16 | -5.93% |
| 3 Months | 2.49 | 2.825 | 1.895 | 2.40 | 179,803 | 0.05 | 2.01% |
| 6 Months | 2.20 | 4.2984 | 1.895 | 2.87 | 315,008 | 0.34 | 15.45% |
| 1 Year | 3.20 | 4.2984 | 1.33 | 2.65 | 265,597 | -0.66 | -20.63% |
| 3 Years | 19.80 | 20.1099 | 1.33 | 6.58 | 424,910 | -17.26 | -87.17% |
| 5 Years | 19.95 | 34.79 | 1.33 | 9.07 | 408,357 | -17.41 | -87.27% |
Athira Pharma Description
| Athira Pharma Inc is a biotechnology company focused on developing small molecules to restore neuronal health and stop neurodegeneration. The company is developing treatments for Alzheimer's disease and Parkinson's disease. |
